Pfizer Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2019
Total Assets: $167.59B
Liabilities Breakdown FY2019
Total Liabilities: $104.15B
Asset Breakdown
Total Assets: $167.59B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.12B | 0.7% |
| Accounts Receivable | $6.77B | 4.0% |
| Inventory | $7.07B | 4.2% |
| Property, Plant & Equipment | $12.97B | 7.7% |
| Goodwill | $48.18B | 28.7% |
| Intangible Assets | $33.94B | 20.2% |
| Other Assets | $57.55B | 34.3% |
Liabilities Breakdown
Total Liabilities: $104.15B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.89B | 3.7% |
| Long-Term Debt | $35.96B | 34.5% |
| Other Liabilities | $64.31B | 61.7% |